Full Press Release Details
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments.
CRSP
CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
Key Takeaway: CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
Price reaction · baseline $56.8 (2024-05-22 close) · hit after-hours · 1 other CRSP headline(s) in the window, move may be shared
day 0 close · peak
-1.9%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension